THSD4-LRRC49 Fusion FISH Probe
The THSD4-LRRC49 Fusion FISH Probe is used to confirm a fusion of the THSD4 and LRRC49 genes. The fusion of the THSD4 and LRRC49 genes has been associated with Breast Invasive Carcinoma, Breast Invasive Carcinoma, Breast Invasive Carcinoma, Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma, Breast Invasive Carcinoma, and Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| THSD4-LRRC49-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-RERE | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-REOR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-REGO | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-REGR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-OROR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GORE | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GROR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| THSD4-LRRC49-20-AQAQ | 20 (40 μL) | 200 μL |
|
LRRC49 Gene Summary
The Leucine Rich Repeat Containing 49 (LRRC49) gene is located on chr15 :71184927-71342436 at 15q23.
Gene Name: Leucine Rich Repeat Containing 49
Chromosome: CHR15: 71184927 -71342436
Locus: 15q23
THSD4 Gene Summary
The Thrombospondin Type 1 Domain Containing 4 (THSD4) gene is located on chr15 :71433787-72075722 at 15q23.
Gene Name: Thrombospondin Type 1 Domain Containing 4
Chromosome: CHR15: 71433787 -72075722
Locus: 15q23
Gene Diseases
The THSD4 LRRC49 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Breast Invasive Carcinoma |
| Breast Invasive Carcinoma |
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
| Breast Invasive Carcinoma |
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|